This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Should You Retain Assurant (AIZ) Stock in Your Portfolio?
by Zacks Equity Research
Assurant (AIZ) stands to gain from organic growth across distribution channels, higher yields on fixed maturity securities, rise in invested assets and a solid capital position.
Why It's Worth Betting on Kinsale Capital (KNSL) Stock Now
by Zacks Equity Research
Kinsale Capital (KNSL) stands to gain from higher submission activity from brokers, increased rates across most lines of business and improved interest rates.
Add 5 Low-Beta Stocks to Your Portfolio to Counter Volatility
by Nalak Das
We have narrowed our search to five low-beta stocks. These are: DPZ, ACGL, AZPN, MLM, ERIE.
Reasons Why AXIS Capital (AXS) Stock is an Attractive Pick Now
by Zacks Equity Research
AXIS Capital (AXS) stands to gain from higher net investment income, strong market presence, better pricing, solid balance sheet and effective capital deployment.
Should You Retain W.R. Berkley (WRB) Stock in Your Portfolio?
by Zacks Equity Research
W.R. Berkley (WRB) is gaining momentum owing to higher premiums, lower claims frequency in certain lines of business and sufficient liquidity.
Is Arch Capital Group (ACGL) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Arch Capital Group (ACGL) and Assurant (AIZ) have performed compared to their sector so far this year.
Should You Retain Travelers (TRV) Stock in Your Portfolio?
by Zacks Equity Research
Travelers (TRV) stands to gain from strong returns from the non-fixed income portfolio, positive renewal premium change, high levels of retention and effective capital deployment.
Selective Insurance (SIGI) Q2 Earnings Meet, Revenues Rise Y/Y
by Zacks Equity Research
Selective Insurance's (SIGI) Q2 results reflect higher pre-tax investment income from fixed income securities portfolio, renewal pure price increases, stable retention and strong new business.
Best Momentum Stocks to Buy for August 3rd
by Zacks Equity Research
RCL, EDU and ACGL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 3, 2023.
New Strong Buy Stocks for August 3rd
by Zacks Equity Research
ERIE, RCL, EDU, ACGL and RM have been added to the Zacks Rank #1 (Strong Buy) List on August 3, 2023.
NMI Holdings (NMIH) Q2 Earnings Top Estimates, Increase Y/Y
by Zacks Equity Research
NMI Holdings' (NMIH) Q2 results reflect lower operating expenses, higher premiums & net investment income and increasing persistency, which drove growth in the company's high-quality insured portfolio.
Assurant (AIZ) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Assurant's (AIZ) second-quarter results reflect higher lender-placed net earned premiums, average insured values and premium rates and improved net investment income, offset by higher expenses.
Hartford Financial (HIG) Q2 Earnings Beat on Commercial Lines Unit
by Zacks Equity Research
Hartford Financial's (HIG) Q2 results reflect growing premiums in the Group Benefits business and improved net investment income across Hartford Funds unit, partly offset by higher catastrophe losses.
Kinsale Capital (KNSL) Q2 Earnings Beat, Premiums Rise Y/Y
by Zacks Equity Research
Kinsale Capital's (KNSL) Q2 results reflect an improved pricing environment, premium growth, favorable loss experience and higher net investment income.
Cincinnati Financial (CINF) Q2 Earnings Top, Premiums Rise Y/Y
by Zacks Equity Research
Cincinnati Financial's (CINF) Q2 results reflect higher underwriting income, net investment income and an improved combined ratio, partly offset by escalating costs.
Arch Capital (ACGL) Q2 Earnings & Revenues Beat, Rise Y/Y
by Zacks Equity Research
Arch Capital (ACGL) Q2 results reflect improved premiums and higher net investment income on the back of improved Insurance and Reinsurance segment performance.
Arch Capital (ACGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Arch Capital (ACGL) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Arch Capital Group (ACGL) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Arch Capital (ACGL) delivered earnings and revenue surprises of 16.36% and 2.25%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Arch Capital, Assurant, American Equity Investment Life, Aon and Aflac
by Zacks Equity Research
Arch Capital, Assurant, American Equity Investment Life, Aon and Aflac are included in this Analyst Blog.
What's in the Cards for Willis Towers (WTW) in Q2 Earnings?
by Zacks Equity Research
Willis Towers' (WTW) second-quarter results are likely to have reflected gains from reward-based advisory services, higher levels of project work, and the expansion of local portfolios and lower expenses.
Will Rising Costs Hurt Kinsale Capital's (KNSL) Q2 Earnings?
by Zacks Equity Research
Kinsale Capital's (KNSL) second-quarter results are likely to have reflected higher net premiums earned and investment income.
5 Insurers Set to Outperform Estimates This Earnings Season
by Tanuka De
Better pricing, exposure growth, accelerated digitalization and sturdy capital are expected to help ACGL, AIZ, AEL, AON and AFL outperform Q2 earnings estimates.
Why Earnings Season Could Be Great for Arch Capital (ACGL)
by Zacks Equity Research
Arch Capital (ACGL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Beat in Store for Everest Re (EG) This Earnings Season?
by Zacks Equity Research
Everest Re's (EG) second-quarter results are likely to benefit from diversified growth across most lines of business, increase in Casualty and Financial Lines, higher new money yields and prudent underwriting.
CME Group (CME) Set to Report Q2 Earnings: What to Expect
by Zacks Equity Research
CME Group's (CME) Q2 earnings are likely to have been aided by improved clearing, transaction fees and other revenues, and market data and information services. However, higher expenses might have been an offset.